Living your best life with arthritis.

New online forum to improve biosimilars education

Arthritis Consumer Experts today announced the launch of the Biosim•Exchange

Arthritis Consumer Experts today announced the launch of the Biosim•Exchange – the first central resource in Canada for consumers to find timely, fact-based information on biosimilars safety and effectiveness and report on public and private health insurance formulary policy or listing decisions on biosimilars.

Biosim Exchange Banner“There is a real need for balanced, evidence-based information on biosimilars. Our aim with the Biosim•Exchange is to help patients better understand biosimilars and their place among other inflammatory arthritis treatments. With this knowledge, patients can have a full therapy conversation with their rheumatologist (or other specialist) in order to best decide on their choice of medications, including originator biologics or biosimilars,” said Cheryl Koehn, Founder & President, Arthritis Consumer Experts.

To view the Biosim•Exchange, please click here: http://bit.ly/JHBiosimExch.

ACE encourages you to share the Biosim•Exchange with other patients, your friends and family.

We look forward to your questions and comments and hearing about your experience with biosimilars.